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Sjaastad & Spierings described “Hemicrania continua”
(HC) in 1984 [1]. In 2001, succinct criteria were presented
[2]: permanent hemicrania, pain intensity: mild-moderate,
(but occasionally - severe) and indomethacin dosage <
150 mg daily. In addition, relative shortage of “local” auto-
nomic phenomena, relative lack of “migraine symptoms”
and of “cervicogenic” features. Such patients generally had
tried legion drugs, with little effect. Such trials equal the
usage of placebo. These guidelines seemed to function
close to optimally. Then, criteria of the International
Headache Society (IHS) (ICHD-III beta classification)
came along. Surprisingly, they were transferred from a
recent review article by Goadsby [3], almost word by
word, despite the existence of a committee of intelligent
and knowledgeable colleagues. There is an abundance of
failures in the actual scheme. It is unacceptable to include
as mandatory criteria, facial/forehead autonomic features.
In this way, e.g. sweating becomes prominent - 33%,
against a subjective feeling of sweating in only 6% of our
series (ratio: 5.5). Objectively, by quantitative evaporime-
try, there was no facial asymmetry in all our 8 cases.
There were 12 autonomic phenomena in this category [3],
with a mean ratio between Goadsby’s/our figures of 4.4.
When made mandatory, autonomic features will create
bogus cases. Bogus cases necessitate ultra-high indometha-
cin dosages; such dosages have an unspecific, analgesic
effect, on various headaches. Our mean indomethacin
continuation dosage was: 83 mg (range: 50-150), while in
Goadsby’s series it was 176 mg (25-500). HC is the unilat-
eral headache with the least “local” autonomic features,
“migrainous” and “vascular” components. It is a rather
“pure” headache. The present classification brings HC
nearer to other unilateral headaches with local autonomic
symptoms, a misunderstood policy. CPH is exceptional
with clinical similarities; the absolute indomethacin effect
suggests a shared, core pathogenesis.
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